Steward Partners Investment Advisory’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$52.9K Buy
825
+14
+2% +$897 ﹤0.01% 2447
2025
Q1
$51.5K Buy
811
+229
+39% +$14.5K ﹤0.01% 2370
2024
Q4
$38.7K Buy
582
+19
+3% +$1.26K ﹤0.01% 2469
2024
Q3
$39.3K Hold
563
﹤0.01% 2357
2024
Q2
$36.5K Hold
563
﹤0.01% 2252
2024
Q1
$36.4K Hold
563
﹤0.01% 2257
2023
Q4
$37.1K Sell
563
-128
-19% -$8.43K ﹤0.01% 2120
2023
Q3
$39.4K Hold
691
﹤0.01% 2016
2023
Q2
$42.3K Hold
691
﹤0.01% 1948
2023
Q1
$43.4K Sell
691
-6
-0.9% -$377 ﹤0.01% 1917
2022
Q4
$44.3K Buy
697
+128
+22% +$8.13K ﹤0.01% 1887
2022
Q3
$34K Hold
569
﹤0.01% 1970
2022
Q2
$33K Sell
569
-1,785
-76% -$104K ﹤0.01% 1994
2022
Q1
$146K Sell
2,354
-11,931
-84% -$740K ﹤0.01% 1430
2021
Q4
$1.02M Buy
14,285
+475
+3% +$33.8K 0.02% 682
2021
Q3
$1.03M Buy
13,810
+403
+3% +$30.2K 0.02% 653
2021
Q2
$1.04M Sell
13,407
-871
-6% -$67.4K 0.02% 651
2021
Q1
$1.05M Buy
14,278
+620
+5% +$45.8K 0.02% 626
2020
Q4
$958K Sell
13,658
-135
-1% -$9.47K 0.02% 570
2020
Q3
$781K Buy
13,793
+894
+7% +$50.6K 0.02% 549
2020
Q2
$752K Buy
12,899
+327
+3% +$19.1K 0.02% 527
2020
Q1
$584K Buy
12,572
+1,810
+17% +$84.1K 0.02% 528
2019
Q4
$601K Buy
10,762
+67
+0.6% +$3.74K 0.02% 582
2019
Q3
$506K Buy
10,695
+213
+2% +$10.1K 0.02% 576
2019
Q2
$560K Sell
10,482
-502
-5% -$26.8K 0.02% 529
2019
Q1
$606K Sell
10,984
-1,769
-14% -$97.6K 0.03% 463
2018
Q4
$600K Sell
12,753
-591
-4% -$27.8K 0.03% 443
2018
Q3
$793K Hold
13,344
0.04% 399
2018
Q2
$730K Sell
13,344
-165
-1% -$9.03K 0.04% 371
2018
Q1
$664K Buy
13,509
+659
+5% +$32.4K 0.05% 356
2017
Q4
$606K Buy
12,850
+337
+3% +$15.9K 0.05% 325
2017
Q3
$624K Buy
12,513
+200
+2% +$9.97K 0.06% 261
2017
Q2
$562K Buy
12,313
+12,206
+11,407% +$557K 0.06% 254
2017
Q1
$4K Buy
+107
New +$4K ﹤0.01% 1186